J&J(US:JNJ) ZACKS·2026-01-14 16:01Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Johnson & Johnson (JNJ) due to higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Johnson & Johnson is expected to report quarterly earnings of $2.50 per share, reflecting a year-over-year increase of +22.6% [3][19]. - Revenues are projected to be $24.12 billion, which is a 7.1% increase from the same quarter last year [3][19]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.36% over the last 30 days, indicating a reassessment by analysts [4][19]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.80%, suggesting a bearish outlook from analysts [12][19]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but its predictive power is stronger for positive readings [9][10]. - Johnson & Johnson's current Zacks Rank is 3 (Hold), which complicates predictions of an earnings beat [12][20]. Historical Performance - In the last reported quarter, Johnson & Johnson exceeded the expected earnings of $2.77 per share by delivering $2.80, resulting in a surprise of +1.08% [13]. - The company has beaten consensus EPS estimates in each of the last four quarters [14][20]. Conclusion - Despite the potential for an earnings beat, various factors may influence stock movement, and the current indicators suggest that Johnson & Johnson may not be a compelling candidate for an earnings surprise [15][17].